Technology R&D

Assisting the rapid development of TIMYEE HEALTH Industry

RESEARCH DIRECTION II

1

- ABOUT TIANKUN BIOTECH

Xi'an Tiankun Biotech Co., Ltd. is a new integrated health management ecosystem provider, is based on the life sciences, bioengineering, the creation of major new medicines and the modernization of Traditional Chinese Medicine project resulting in the transformating into an innovative high-tech industrial company. From the very beginning, we have been committed to promoting the harmonious natural development of human beings, and actively exploring the in-depth development, application and promotion of the latest scientific and technological achievements in physical health and environmental health.

We take "bio-patent + Internet + private new retail" as the core; in the field of "big health science and technology pharmaceutical industry + big health science and technology beauty industry + big health science and technology food" comprehensive and high-speed development, focusing on bio-intelligence, beauty and anti-aging, big health science and technology health industry chain, with a number of intellectual property rights accumulation and 24 independent products. We have accumulated many intellectual property rights and 24 patents of independent research and development.

 

- CORE R&D TEAM

Zeng Xianjun, our R&D director, set up a life science R&D team in 2017 to carry out the development of new Chinese medicine and big health products. The R&D products cover functional types such as enhancing immunity, increasing bone density, regulating blood lipids, endocrine adjustment, etc. We have won wide recognition in the industry for our reliable quality, professional services and rich product lines.

图片名称

Zeng Xianjun

R&D Director

Master's degree of Xi'an Jiaotong University

- With over 20 years of experience in medicine research and development.
- Academic Achievements: Leading the research and development of cough capsules, calcium gluconate oral solution, ketoconazole ointment, lamivudine oral solution, bismuth potassium citrate capsules, bismuth colloidal capsules, moxifloxacin hydrochloride, and moxifloxacin sodium chloride injection, etc., which have successfully gained governmental approvals.

- PATENT

1-3
1-2
1-1
3
2
1